Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Danyelza Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Elrexfio Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Extavia Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Infergen Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Jetrea Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Artemisinin Combination Therapy Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Artemisinin...
-
- Final results from first pancreatic cancer study in Montreal demonstrate 81% disease control rate, or 87% excluding the first two patients - - Immune markers demonstrate immune system preservation...
-
Io Therapeutics announced today data demonstrating effectiveness of its RXR agonist IRX4204 for synergistic killing of HER2+ breast cancer with CAR-T cells
-
Io Therapeutics announced at the American Society of Hematology studies of their RXR agonist IRX4204 in combination with CAR-T cells for multiple myeloma
-
Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "United States Carboxy Therapy Market, By Region, By Competition, Opportunities & Forecast, 2020-2030F" report has been added to ...